Goldman Sachs
NTUS

Goldman Sachs’s Natus Medical Inc NTUS Stock Holding History

Goldman Sachs’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-294,571
Closed -$9.65M – 6854
2022
Q2 		$9.65M Sell
294,571
-205,249
-41% -$6.49M ﹤0.01% 2555
2022
Q1 		$13.1M Sell
499,820
-104,188
-17% -$2.54M ﹤0.01% 2415
2021
Q4 		$14.3M Sell
604,008
-73,271
-11% -$1.81M ﹤0.01% 2430
2021
Q3 		$17M Buy
677,279
+4,630
+0.7% +$118K ﹤0.01% 2227
2021
Q2 		$17.5M Buy
672,649
+96,139
+17% +$2.62M ﹤0.01% 2171
2021
Q1 		$14.8M Sell
576,510
-122,410
-18% -$3.14M ﹤0.01% 2200
2020
Q4 		$14M Sell
698,920
-108,573
-13% -$2.13M ﹤0.01% 2167
2020
Q3 		$13.8M Buy
807,493
+178,756
+28% +$3.38M ﹤0.01% 2043
2020
Q2 		$13.7M Sell
628,737
-67,219
-10% -$1.54M ﹤0.01% 2003
2020
Q1 		$16.1M Buy
695,956
+270,966
+64% +$7.88M 0.01% 1684
2019
Q4 		$14M Buy
424,990
+314,380
+284% +$10.1M ﹤0.01% 2165
2019
Q3 		$3.52M Buy
110,610
+52,633
+91% +$1.53M ﹤0.01% 3117
2019
Q2 		$1.49M Sell
57,977
-76,398
-57% -$1.95M ﹤0.01% 3733
2019
Q1 		$3.41M Buy
134,375
+18,496
+16% +$552K ﹤0.01% 3254
2018
Q4 		$3.94M Sell
115,879
-15,044
-11% -$489K ﹤0.01% 3081
2018
Q3 		$4.67M Buy
130,923
+1,537
+1% +$54.3K ﹤0.01% 3041
2018
Q2 		$4.46M Sell
129,386
-4,789
-4% -$168K ﹤0.01% 3039
2018
Q1 		$4.51M Buy
134,175
+24,259
+22% +$768K ﹤0.01% 2982
2017
Q4 		$4.2M Buy
109,916
+5,924
+6% +$237K ﹤0.01% 3171
2017
Q3 		$3.9M Buy
103,992
+11,981
+13% +$423K ﹤0.01% 3387
2017
Q2 		$3.43M Buy
92,011
+31,994
+53% +$1.16M ﹤0.01% 3377
2017
Q1 		$2.36M Sell
60,017
-72,615
-55% -$2.72M ﹤0.01% 3586
2016
Q4 		$4.62M Buy
132,632
+42,015
+46% +$1.65M ﹤0.01% 3125
2016
Q3 		$3.56M Sell
90,617
-17,603
-16% -$702K ﹤0.01% 3346
2016
Q2 		$4.09M Sell
108,220
-7,931
-7% -$266K ﹤0.01% 3027
2016
Q1 		$4.46M Sell
116,151
-30,007
-21% -$1.12M ﹤0.01% 2808
2015
Q4 		$7.02M Sell
146,158
-3,795
-3% -$176K ﹤0.01% 2532
2015
Q3 		$5.92M Buy
149,953
+8,933
+6% +$380K ﹤0.01% 2736
2015
Q2 		$6M Sell
141,020
-12,037
-8% -$480K ﹤0.01% 2808
2015
Q1 		$6.04M Sell
153,057
-9,290
-6% -$343K ﹤0.01% 2726
2014
Q4 		$5.85M Buy
162,347
+56,124
+53% +$1.89M ﹤0.01% 2843
2014
Q3 		$3.13M Buy
106,223
+25,067
+31% +$692K ﹤0.01% 3487
2014
Q2 		$2.04M Sell
81,156
-7,632
-9% -$189K ﹤0.01% 3980
2014
Q1 		$2.29M Sell
88,788
-193,539
-69% -$4.88M ﹤0.01% 3841
2013
Q4 		$6.35M Buy
282,327
+202,781
+255% +$3.92M ﹤0.01% 2810
2013
Q3 		$1.13M Buy
79,546
+67,495
+560% +$903K ﹤0.01% 4490
2013
Q2 		$164K Buy
+12,051
New +$164K ﹤0.01% 5687

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Goldman Sachs's NTUS Position: Q3 2022 in Review

Goldman Sachs sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 294,571 shares — an estimated $9.65M sold.

Goldman Sachs first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $17.5M in Q2 2021. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Goldman Sachs reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Goldman Sachs sold 294,571 Natus Medical Inc shares in Q3 2022, an estimated $9.65M.
  • Goldman Sachs first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • Goldman Sachs's Natus Medical Inc position peaked at $17.5M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.